DJIA 17,804.80 26.65 0.15%
NASDAQ 4,765.38 16.98 0.36%
S&P 500 2,070.65 9.42 0.46%
market minute promo

EXACT Sciences Corp (NASDAQ: EXAS)

25.97 -1.41 (-5.15%)

REAL-TIME: Last trade at


company name or ticker

Recent Quotes

EXAS $25.97 -5.15%
1D 1W 3M 6M 1Y 2Y 3Y
Today's Open $27.51
Previous Close $27.38
Daily Range $25.66 - $28.69
52-Week Range $10.69 - $29.97
Market Cap $2.2B
P/E Ratio -26.58
Dividend (Yield) $0.00 (0.0%)
Volume 6,083,051
Average Daily Volume 1,509,803
Current FY EPS -$1.25

Sector

Healthcare

Industry

Drugs

EXACT Sciences Corp (EXAS) Description

An applied genomics company that develops proprietary DNA-based technologies for use in the detection of cancer. Website: http://www.exactsciences.com/

News & Commentary Rss Feed

3 Traits of the Best Healthcare Stocks in 2014

The best healthcare stocks in 2014 saw their shares gain as much as 400% because they exhibited at least one of the following three key traits.

Adam Feuerstein's 2014 Biotech Stock Report Card (No Grading on a Curve)

Exact Sciences (EXAS) Crumbles: Stock Falls by 6.7% - Tale of the Tape

Mid-Afternoon Market Update: NASDAQ Drops 0.4%; Nucor Shares Slide After Weak Profit Forecast

Mid-Afternoon Market Update: NASDAQ Drops 0.4%; Nucor Shares Slide After Weak Profit Forecast

Mid-Day Market Update: U.S. Stocks Turn Higher; Talisman Shares Jump Following Announcement of Repso

Mid-Day Market Update: U.S. Stocks Turn Higher; Talisman Shares Jump Following Announcement of Repsol Deal

Mid-Day Market Update: U.S. Stocks Turn Higher; Talisman Shares Jump Following Announcement of Repso

Mid-Day Market Update: U.S. Stocks Turn Higher; Talisman Shares Jump Following Announcement of Repsol Deal

First Week of EXAS July 2015 Options Trading

The Nominees for Best Biotechnology Co. CEO of 2014 Are...

Listen Up Insurance Companies, Cologuard Will Save You Money

See More EXAS News...

EXAS's Top Competitors

EXAS $25.97 (-5.15%)
Current stock: EXAS
AMGN $170.17 (1.00%)
Current stock: AMGN
GILD $108.45 (2.76%)
Current stock: GILD
BIIB $360.67 (1.97%)
Current stock: BIIB